Clinical Trial Update: Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038 [Phase 2]

View source ↗

Summary

Phase 2 trial update on a novel double-target therapy combined with chemotherapy for first-line treatment of HER2-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: HER2-positive Breast Cancer | Phase 2 | Status: UNKNOWN